|
Volumn 21, Issue 10, 2007, Pages 1373-1375
|
Pharmacokinetics of once-daily tenofovir, emtricitabine, ritonavir and fosamprenavir in HIV-infected subjects
a a a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPRENAVIR PHOSPHATE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
RITONAVIR;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DIARRHEA;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG TOLERABILITY;
DYSLIPIDEMIA;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERBILIRUBINEMIA;
HYPOKALEMIA;
HYPONATREMIA;
PRIORITY JOURNAL;
TREATMENT DURATION;
TREATMENT OUTCOME;
ADENINE;
ADOLESCENT;
ADULT;
ANTIVIRAL AGENTS;
CARBAMATES;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
PHOSPHONIC ACIDS;
PHOSPHORIC ACID ESTERS;
REVERSE TRANSCRIPTASE INHIBITORS;
RITONAVIR;
RNA, VIRAL;
SULFONAMIDES;
TREATMENT OUTCOME;
|
EID: 34249984110
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/QAD.0b013e328133f068 Document Type: Article |
Times cited : (10)
|
References (7)
|